RBC Capital cuts Travelers stock price target to $268
RBC Capital Markets adjusted its outlook on Travelers Companies Inc. (NYSE:TRV) shares, reducing the price target to $268 from $273, while maintaining a Sector Perform rating. The $54.8 billion ...
RBC Capital lifts BankUnited stock target to $43, keeps rating
The increased price target reflects the firm's recognition of BankUnited (NYSE:BKU)'s consistent progress and its potential ...
RBC Capital Sticks to Its Buy Rating for Abbott Laboratories (ABT)
In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Abbott Laboratories (ABT – Research Report), ...
RBC Capital Keeps Their Hold Rating on Incyte (INCY)
RBC Capital analyst Brian Abrahams maintained a Hold rating on Incyte (INCY – Research Report) on January 21 and set a price target of $70.00.